Passive protective equipment
Aus coViki
(Unterschied zwischen Versionen)
| Zeile 30: | Zeile 30: | ||
'''[[PPE virus by air ]]''' | '''[[PPE virus by air ]]''' | ||
| − | + | ---- | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
{{tp|p=32201338|t=ä. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy |pdf=|usr=}} | {{tp|p=32201338|t=ä. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
{{tp|p=32213231|t=ä. Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |pdf=|usr=}} | {{tp|p=32213231|t=ä. Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
{{tp|p=32317139|t=2020. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as ?Personal Protective Equipment? for frontline providers exposed in high-risk head and neck and skull base oncology care |pdf=|usr=}} | {{tp|p=32317139|t=2020. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as ?Personal Protective Equipment? for frontline providers exposed in high-risk head and neck and skull base oncology care |pdf=|usr=}} | ||
{{tp|p=32319881|t=2020. May hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection?|pdf=|usr=}} | {{tp|p=32319881|t=2020. May hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection?|pdf=|usr=}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
{{tp|p=32551877|t=2020. Is sweat a possible route of transmission of SARS-CoV-2?|pdf=|usr=010}} | {{tp|p=32551877|t=2020. Is sweat a possible route of transmission of SARS-CoV-2?|pdf=|usr=010}} | ||
| − | |||
| − | |||
| − | |||
{{tp|p=32563530|t=2020. Feline Infectious Peritonitis: Update on Pathogenesis, Diagnostics, and Treatment.|pdf=|usr=018}} | {{tp|p=32563530|t=2020. Feline Infectious Peritonitis: Update on Pathogenesis, Diagnostics, and Treatment.|pdf=|usr=018}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| + | {{ttp|p=32652214|t=2020. Factors affecting stability and infectivity of SARS-CoV-2.|pdf=|usr=015}} | ||
{{tp|p=32710248|t=2020. How to Leverage Collaborations Between the BME Community and Local Hospitals to Address Critical Personal Protective Equipment Shortages During the COVID-19 Pandemic.|pdf=|usr=014}} | {{tp|p=32710248|t=2020. How to Leverage Collaborations Between the BME Community and Local Hospitals to Address Critical Personal Protective Equipment Shortages During the COVID-19 Pandemic.|pdf=|usr=014}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
{{tp|p=32745829|t=2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.|pdf=|usr=017}} | {{tp|p=32745829|t=2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.|pdf=|usr=017}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
{{tp|p=C7267108|t=2020. Rapid Responders: Plastics companies are stepping into the breach to design and deliver life?saving PPE to healthcare workers.|pdf=|usr=015}} | {{tp|p=C7267108|t=2020. Rapid Responders: Plastics companies are stepping into the breach to design and deliver life?saving PPE to healthcare workers.|pdf=|usr=015}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Aktuelle Version vom 29. September 2020, 21:21 Uhr
F further streaming-in related content is here
PPE air filtration and direction
32201338 ä. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy
32213231 ä. Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
32317139 2020. Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as ?Personal Protective Equipment? for frontline providers exposed in high-risk head and neck and skull base oncology care
32319881 2020. May hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection?
32551877 2020. Is sweat a possible route of transmission of SARS-CoV-2?
32563530 2020. Feline Infectious Peritonitis: Update on Pathogenesis, Diagnostics, and Treatment.
| 32652214 2020. Factors affecting stability and infectivity of SARS-CoV-2. |
32710248 2020. How to Leverage Collaborations Between the BME Community and Local Hospitals to Address Critical Personal Protective Equipment Shortages During the COVID-19 Pandemic.
32745829 2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.
C7267108 2020. Rapid Responders: Plastics companies are stepping into the breach to design and deliver life?saving PPE to healthcare workers.
